Table 1.

Chemotherapy Use Across Multiple Series

Study	Study Dates	Use at Start of Study	Use at End of Study
Porter, et. al [15]	1992–2002	—	7% *
Fedeli, et. al [19]	1998–2003	6%	13%
David, et. al [18]	2003–2007	—	1.2% *
Keegan, et. al [22]	1997–2008	11%	15%
Sandhu, et. al [21]	2003–2007	3%	14%
Raj, et. al [20]	2003–2008	—	22% ~
Zaid, et. al [23]	2006–2010	7.6%	20.9%

^*Mean use for pT3

^~Mean use in series